Literature DB >> 21653929

Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines.

Leonardo M Fabbri, Bianca Beghé, Alvar Agusti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21653929     DOI： 10.1136/thoraxjnl-2011-200406

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  14 in total

Review 1.  Prevention of Exacerbations in Chronic Obstructive Pulmonary Disease: Knowns and Unknowns.

Authors:  Alvar Agustí; Peter M Calverley; Marc Decramer; Robert A Stockley; Jadwiga A Wedzicha
Journal:  Chronic Obstr Pulm Dis       Date:  2014-09-25

2.  Fibrinogen and COPD: Now what?

Authors:  Rosa Faner; Alvar Agusti
Journal:  Chronic Obstr Pulm Dis       Date:  2015-01-24

3.  AIMAR survey on COPD phenotypes.

Authors:  Maria Sandra Magnoni; Andrea Rizzi; Alberto Visconti; Claudio F Donner
Journal:  Multidiscip Respir Med       Date:  2014-03-17

Review 4.  Epidemiology and clinical impact of major comorbidities in patients with COPD.

Authors:  Miranda Caroline Smith; Jeremy P Wrobel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-08-27

5.  Simvastatin up-regulates adenosine deaminase and suppresses osteopontin expression in COPD patients through an IL-13-dependent mechanism.

Authors:  Kittipong Maneechotesuwan; Kanda Kasetsinsombat; Adisak Wongkajornsilp; Peter J Barnes
Journal:  Respir Res       Date:  2016-08-24

6.  Simvastatin Suppresses Airway IL-17 and Upregulates IL-10 in Patients With Stable COPD.

Authors:  Kittipong Maneechotesuwan; Adisak Wongkajornsilp; Ian M Adcock; Peter J Barnes
Journal:  Chest       Date:  2015-11       Impact factor: 9.410

Review 7.  Effects of simvastatin in chronic obstructive pulmonary disease: Results of a pilot, randomized, placebo-controlled clinical trial.

Authors:  Catalina Balaguer; Alejandro Peralta; Ángel Ríos; Amanda Iglesias; Josep Lluís Valera; Aina Noguera; Joan B Soriano; Àlvar Agustí; Ernest Sala-Llinas
Journal:  Contemp Clin Trials Commun       Date:  2016-01-14

8.  Statins Dose-Dependently Exert Significant Chemopreventive Effects Against Various Cancers in Chronic Obstructive Pulmonary Disease Patients: A Population-Based Cohort Study.

Authors:  Chun-Chao Chen; Yi-Ping Hsu; Ju-Chi Liu; Pai-Feng Kao; Li-Chin Sung; Chao-Feng Lin; Wen-Rui Hao; Shing-Hwa Liu; Szu-Yuan Wu
Journal:  J Cancer       Date:  2016-09-13       Impact factor: 4.207

9.  Statins dose-dependently exert a significant chemopreventive effect on colon cancer in patients with chronic obstructive pulmonary disease: A population-based cohort study.

Authors:  Ju-Chi Liu; Wen-Rui Hao; Yi-Ping Hsu; Li-Chin Sung; Pai-Feng Kao; Chao-Feng Lin; Alexander T H Wu; Kevin Sheng-Po Yuan; Szu-Yuan Wu
Journal:  Oncotarget       Date:  2016-10-04

10.  Statins dose-dependently exert a chemopreventive effect against lung cancer in COPD patients: a population-based cohort study.

Authors:  Ju-Chi Liu; Tsung-Yeh Yang; Yi-Ping Hsu; Wen-Rui Hao; Pai-Feng Kao; Li-Chin Sung; Chun-Chao Chen; Szu-Yuan Wu
Journal:  Oncotarget       Date:  2016-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.